Filing metadata

Accession number
0000899243-23-009164
Form type
Form 3
Filer
Amylyx Pharmaceuticals, Inc.
CIK
CIK 1658551
Filed
Mar 20, 2023
Reporting period
Mar 16, 2023
Description
Initial ownership

Explore SEC Filings Hub